Cheryl Fossum Graham Joins Knopp Neurosciences as Head of Regulatory and Development Strategy
PITTSBURGH, Oct. 3 /PRNewswire/ -- Knopp Neurosciences Inc. ("Knopp") announced that Cheryl Fossum Graham, M.D., F.C.P., has joined the company as senior vice president of regulatory and development strategy. (Logo: http://www.newscom.com/cgi-bin/prnh/20070924/KNOPPLOGO ) Dr. Graham brings...Dr. Mei receives 2008 Mathilde Solowey Lecture Award in Neurosciences
Dr. Lin Mei, chief of developmental neurobiology at the Medical College of Georgia and Georgia Research Alliance Eminent Scholar in Neuroscience, has received the 2008 Mathilde Solowey Lecture Award in Neurosciences. The annual award, administered by Foundation for Advanced Education in the Sc...Fetal Alcohol Disorders Often Misdiagnosed as ADHD
...eting another's mental states and emotions," study corresponding author Joanne Rovet, a professor at the University of Toronto and senior scientist in neurosciences and mental health at the Hospital for Sick Children. These problems with social cognition and emotion processing "may underlie the severe conduct p...Journal of Alzheimer's Disease once again achieves significant impact factor increase
...his journal is having in the field. As a specialist journal, it is particularly significant that it is ranked among the top journals included in JCR's neurosciences category." ...Forsyth Medical Center participating in Avastin trial for new glioblastoma patients
... trial will enroll 700 participants nationwide, and FRCC is one of the first sites in the country to participate. The trial is part of the hospital's neurosciences program. "Avastin has been shown to be effective in treating various types of cancer, with a low risk of serious side effects, so our hope is that ...Measuring brain atrophy in patients with mild cognitive impairment
... but instead correlated tightly with how a person's cognitive status worsens over time," said co-author Michael Rafii, MD, PhD, assistant professor of neurosciences at UC San Diego. "It's too early to draw a definitive comparison, but it appears that these early changes especially shrinking of the hippocampus m...Knopp Neurosciences Receives Orphan Designation for KNS-760704 for Treatment of ALS
PITTSBURGH, Oct. 15 /PRNewswire/ -- Knopp Neurosciences Inc. ("Knopp") announced that the U.S. Food and Drug Administration's Office of Orphan Products Development has granted orphan drug designation to KNS-760704 for the treatment of amyotrophic lateral sclerosis (ALS). (Logo: http://www.ne...Knopp Neurosciences Initiates Phase 1 Clinical Trial of KNS-760704 in ALS Development Program
PITTSBURGH, Sept. 24 /PRNewswire/ -- Knopp Neurosciences Inc. ("Knopp") today announced the initiation of a Phase 1 clinical trial of KNS-760704, a small molecule therapy in development for the treatment of amyotrophic lateral sclerosis (ALS). (Logo: http://www.newscom.com/cgi-bin/prnh/20070...Solstice Neurosciences Presents Escalating Dose Study at International Congress in Istanbul, Turkey
MALVERN, Pa., June 15, 2007 /PRNewswire/ -- Solstice Neurosciences, Inc. today reported important results from a multicenter, forced dose escalation study of Botulinum Toxin Type B Injectable Solution (Myobloc(R)) recently presented at the 11th International Congress of The Movement Disorders Soci...Advocate Christ Medical Center Using Glue-Like Liquid to Seal Off Brain Aneurysms
...o-and-a-half-hour procedure, Thomas J. Grobelny MD, of the medical center's neurosciences Institute, led a team in use of the substance to eliminate an aneurysm from...ts expertise in the treatment of brain aneurysms, the Christ Medical Center neurosciences Institute also is a leader in the treatment of brain vascular malformations...Penn announces $50M Penn Integrates Knowledge neurosciences initiative
PHILADELPHIA - The University of Pennsylvania will make a major investment in neuroscience, the interdisciplinary study of brain/behavior relationships and nervous-system diseases, with a $50 million contribution from Penn's Health System to endow five new Penn Integrates Knowledge (P...22nd Congress of the European College of Neuropsychopharmacology, Sept. 12-16, 2009, Turkey
... developed out of previously isolated fields, bridges the gap between basic neurosciences and the treatment of neuropsychiatric diseases. It engages a broad range of...uroimmunology or neurochemistry. As an interdisciplinary science related to neurosciences and psychopharmacology (how drugs affect the mind), it includes research of...UT San Antonio researcher wins $917,000 from NIH to study memory
...xas at San Antonio (UTSA) researcher Brian Derrick hopes to soon find out. The UTSA neurobiologist, a member of UTSA's Department of Biology and its neurosciences Institute, has won $917,000 in funding from the National Institutes of Health to research these and other related questions. According to Derrick, ...Aussie and Kiwi researchers make double MS genetic discovery
...ceptibility to the disease, "says Professor Trevor Kilpatrick, Director for neurosciences at the University of Melbourne, who with Dr Justin Rubio of Florey neurosciences Institutes coordinated the international study. "The newly discovered ge...Neuroscientists discover long-term potentiation in the olfactory bulb
... CLEVELAND May 3, 2009 Ben W. Strowbridge, Ph.D, associate professor of Neuroscience and Physiology/Biophysics, and Yuan Gao, a Ph.D. student in the neurosciences program at Case Western Reserve University School of Medicine, are the first to discover a form of synaptic memory in the olfactory bulb, the part of ...Jefferson researcher awarded Landenberger Foundation grant for ALS research
... PHILADELPHIA Piera Pasinelli, Ph.D., co-director of the Frances and Joseph Weinberg Unit for ALS Research at the Farber Institute for neurosciences at Thomas Jefferson University was recently awarded a Margaret Q. Landenberger Research Foundation grant to identify why drug therapies that showed pr...Phasic firing of dopamine neurons is key to brain's prediction of rewards
...uring Parkinson's Disease and with the consumption of psychostimulants such as cocaine and amphetamine," said Paladini, who is also a member of UTSA's neurosciences Institute. Midbrain dopamine neurons fire in two characteristic modes, tonic and phasic, which are thought to modulate distinct aspects of behavior...CHIs 5th Biomarker World Congress: Signature Event with Cutting-Edge Agenda
...fairs, Global Pharmaceutical Research and Development, Abbott Labs Linda C. Surh, M.D., Ph.D., FRCPC, Director, CEDD Global Regulatory Affairs, neurosciences and Pharmacogenetics, GlaxoSmithKline, UK Ole Vesterqvist, Ph.D., Senior Director, Biomarker Lab & Outsourcing, Clinical Translational Medi...Daily consumption of cannabis predisposes to the appearance of psychosis and schizophrenia
...nmental stress in initial psychosis: transversal analysis of the ESPIGAS study", carried out by researcher Miguel Ruiz Veguilla , of the Institute of neurosciences of the University of Granada (Spain) and supervised by professors Manuel Gurpegui Fernndez de Legaria and Jorge Cervilla Ballesteros . Ruiz Vegu...Case Western Reserve researchers develop 'wireless' activation of brain circuits
...o the discovery of a remarkable new way to use light to activate brain circuits with nanoparticles. Ben Strowbridge, an associate professor in the neurosciences department in the Case Western Reserve School of Medicine and Clemens Burda, an associate professor in chemistry, say it's rare in science that people...Psylin Neurosciences Commences Development of Compound for Depression
SAN DIEGO, April 20 /PRNewswire/ -- Psylin Neurosciences Inc., a joint venture biotechnology company spun out of Amylin Pharmaceuticals, Inc. and PsychoGenics, Inc. announced today that it has initiated IND-enabling development of a novel compound, PSN0041, for the treatment of depression. ...Amarin Signs Agreement to Acquire Ester Neurosciences
Adds Promising Phase II Neurology Candidate $8.1 Million Financing in Connection With Acquisition Reverse Stock Split Planned for January 2008 LONDON, December 5 /PRNewswire-FirstCall/ -- Amarin Corporation plc (NASDAQ: AMRN ) today announced that the Compan...Otonomy Introduces Scientific Advisory Board
...UCSD and director of otolaryngology research at the San Diego Veterans Affairs Medical Center. He also serves on the executive committees for the UCSD neurosciences and the UCSD/SDSU audiology doctoral programs. His research focuses on the development, damage, survival and regeneration of hair cells, regulation of...Intellect Neurosciences, Inc. Issues Letter to Shareholders From Its Chairman and CEO
...olders from Dr. Daniel Chain, its Chairman and CEO. Dear Shareholders, It is my privilege to serve as Chairman and CEO of Intellect neurosciences Inc., which I helped found in 2005. As this year draws to a close, I would like to update you regarding the Company's activities and achievements. I a...Amarin Announces Financial Results for Fourth Quarter and Full Year 2007
...ssets Intangible assets of $19,916,000 relate to the acquisition of Ester neurosciences Limited on December 5, 2007 representing the upfront acquisition considera...achievement of a certain milestone as a result of the acquisition of Ester neurosciences Limited on December 5, 2007. The achievement of this milestone is consider...Verenium Appoints John F. Dee to Board of Directors
...d look forward to his continuing involvement." Mr. Dee served as President, Chief Executive Officer, and Director of Hypnion, Inc., a privately-held neurosciences drug discovery company, from its founding in July 2000 through its $315 million acquisition by Eli Lilly and Company in April 2007. Before Hypnion, Mr...Evotec Announces Financial Results for 2007
...ble to the Oxford-based laboratory operations, plus a further impairment charge of EUR 3.2m related to earlier discovery projects acquired with Evotec neurosciences that have been discontinued for strategic prioritization reasons. On December 31, 2007 Evotec held cash and investments of EUR 93.7m compared to EUR...Elekta Chosen to Deliver Sophisticated Brain Mapping Technology to Froedtert Hospital in Milwaukee
... "We look forward to soon becoming the site of the first whole-head Magnetoencephalography lab in the state," says Elizabeth Ragalie, Director of the neurosciences Center at Froedtert Hospital. "We intend to use the MEG in our epilepsy program as a powerful new tool for pre-surgical planning. The non-invasive and...